JO
IMVT icon

John Overdeck’s Immunovant IMVT Stock Holding History

John Overdeck’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,331
Closed -$205K – 3169
2024
Q1 		$205K Sell
6,331
-72,768
-92% -$2.65M ﹤0.01% 2714
2023
Q4 		$3.33M Sell
79,099
-267,297
-77% -$9.84M 0.01% 1206
2023
Q3 		$13.3M Sell
346,396
-663,087
-66% -$15M 0.04% 503
2023
Q2 		$19.1M Buy
1,009,483
+36,613
+4% +$683K 0.05% 418
2023
Q1 		$15.1M Buy
972,870
+615,833
+172% +$10.7M 0.04% 453
2022
Q4 		$6.34M Buy
357,037
+98,470
+38% +$1.24M 0.02% 747
2022
Q3 		$1.44M Sell
258,567
-291,816
-53% -$1.43M ﹤0.01% 1302
2022
Q2 		$2.15M Sell
550,383
-271,486
-33% -$1.17M 0.01% 1161
2022
Q1 		$4.53M Sell
821,869
-31,659
-4% -$197K 0.01% 969
2021
Q4 		$7.27M Sell
853,528
-290,783
-25% -$2.4M 0.02% 977
2021
Q3 		$9.94M Sell
1,144,311
-130,838
-10% -$1.18M 0.02% 782
2021
Q2 		$13.5M Buy
1,275,149
+504,584
+65% +$7.05M 0.03% 647
2021
Q1 		$12.4M Buy
770,565
+737,829
+2,254% +$19.5M 0.03% 617
2020
Q4 		$1.51M Sell
32,736
-27,609
-46% -$1.28M ﹤0.01% 1688
2020
Q3 		$2.12M Buy
60,345
+51,198
+560% +$1.54M 0.01% 1264
2020
Q2 		$223K Buy
+9,147
New +$196K ﹤0.01% 2577

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

John Overdeck's IMVT Position: Q2 2024 in Review

John Overdeck sold out of Immunovant (IMVT) in Q2 2024, closing a stake of 6,331 shares — an estimated $205K sold.

John Overdeck first reported a position in IMVT in Q2 2020 and held it in 16 quarters. The position peaked at $19.1M in Q2 2023. 197 funds tracked by Wall St. Rank hold IMVT as of Q2 2024.

  • John Overdeck reported no remaining Immunovant position as of Q2 2024 after selling out during the quarter.
  • John Overdeck sold 6,331 Immunovant shares in Q2 2024, an estimated $205K.
  • John Overdeck first reported a position in Immunovant in Q2 2020 and held it in 16 quarters.
  • John Overdeck's Immunovant position peaked at $19.1M in Q2 2023.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.